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Introduction
well-established that sustained GLP-1R antagonism (with exendin (9-39)) impairs glucose 138 tolerance, decreases insulin secretion and causes hyperglycaemia (D'Alessio et al., 1996; 139 Edwards et al., 1999; Kolligs, Fehmann et al., 2002; Green et al., 2005; Scrocchi et al., 140 1996) . As MSG is proposed to be an obesogen it seems logical to investigate whether it can 141 disrupt the GLP-1/GLP-1R axis. 142 This is the first study assessing a potential obesogenic mechanism for MSG and the aims are in 75 cm 2 tissue culture flasks (Nunc, Roskilde, Denmark) at 37 °C with 5% CO2 and 95% 164 humidity. The cells were cultured routinely in Dulbecco's modified Eagle medium (DMEM) 165 media with Glutamax, 10% foetal bovine serum (FBS), 1% penicillin and streptomycin (50 166 U/ml) and 50 mg/ml G418. Cells were grown in plating media (DMEM with Glutamax, 1% 167 FBS, 1% penicillin and streptomycin (50 U/ml)) for 24 h prior to running the assay. Test 168 compounds and standards were diluted in assay media (DMEM with Glutamax, 1% penicillin 169 and streptomycin (50 U/ml)). The assay has been validated with cells up to a passage of 30 170 (Thermo Scientific, UK). 171 pGIP/neo: STC-1 cells are an enteroendocrine (EE) cell model and its GLP-1 secretory 172 ability has been extensively investigated (Gillespie et al., 2015; Jafri et al., 2016) In addition to visual inspection of cells under the microscope to evaluate cell morphology and 180 attachment, two cell viability assays were used to assess cytotoxic effects of MSG exposure. Sunrise spectrophotometer at 570 nm with a reference filter at 630 nm (TECAN, 193 Switzerland). Samples were tested in triplicate and in three independent exposures. Viability The Cellomics® HCS reagent series multiparameter cytotoxicity assay was performed 230 according to the manufacturer's instructions. pGIP/neo: STC-1 cells were seeded 6 x 10 4 in 231 96 well plates 24 hours prior to the assay. Briefly, mitochondrial membrane potential dye was 232 prepared by adding 117 μl of anhydrous DMSO to make a 1 mM stock. Following incubation 233 (3 h or 72 h), 50 μl of live cell stain was added to each well for 30 min at 37 °C and protected assay there was sufficient justification for looking at potential cytotoxic markers on HCA.
289
Similiarly, MTT assays showed no significant change in viability of the U2OS-GLP1R-EGFP 290 cells following 1 h exposure to MSG (0.5, 5, 50, 250 and 500 μg/ml) (data not shown). 
Effects of 3 h exposure of MSG on GLP-1 secretion 294
Following 3 h exposure of pGIP/neo: STC-1 cells to lower MSG concentrations (0.5-250 295 μg/ml) did not significantly affect GLP-1 secretion. However, at 500 μg/ml, MSG stimulated a significant 9.6 pg /10 6 increase in GLP-1 secretion (22.4 pg /10 6 cells in 500 μg/ml MSG vs. 297 12.8 pg /10 6 cells in control; P < 0.001) (Fig.2) . 298 299
Effects of 72 h exposure of MSG on GLP-1 secretion 300
Similarly 72 h exposure of pGIP/neo: STC-1 cells to lower MSG concentrations (0.5-250 301 μg/ml) did not significantly affect GLP-1 secretion. However, at 500 μg/ml MSG there was a 302 significant decrease in GLP-1 secretion by 35.9 pg/10 6 cells (45.4 pg /10 6 cells in 500 μg/ml 303 MSG vs 81.4 pg /10 6 cells in control P < 0.05) (Fig.3) . Mitochondrial membrane potential dye was used to measure mitochondrial health, 310 specifically mitochondrial membrane potential and mitochondrial mass. For 3 h MSG 311 exposure no cytotoxicity was observed at any MSG concentrations (data not shown).
312
However, following 72 h exposure, 250 μg/ml MSG decreased cell number by 11.8% (P < 313 0.05), increased nuclear area by 23.9% (P < 0.001) and decreased mitochondrial membrane 314 potential by 13% (P < 0.05). MSG (500 μg/ml) decreased cell number by 26.7% (P < 0.001), 315 increased nuclear area by 29.8% (P < 0.001), increased mitochondrial mass by 16.3% (P < 316 0.01) and decreased mitochondrial membrane potential by 21.6% (P < 0.001) ( Fig. 4 and 5) . 
GLP-1R internalisation assay 319
A standard curve was generated using various concentrations of GLP-1 (1-300 nM) to drive 320 receptor internalisation (Fig.6 ). The EC50 value was calculated as 37 nM GLP-1.
321
MSG did not cause internalization of the GLP-1R in U2OS-GLP1R-EGFP cells.
322
Furthermore, exposure to MSG (0.5-500 μg/ml) during the period of exposure to GLP-1 did 323 not affect GLP-1-mediated internalisation of the GLP-1R (Figure 7) .
Discussion

326
Associations between MSG consumption and increased incidence of diabetes and obesity 327 have been reported in both human and animal studies (He et al., 2011; Insawang et al. 2012; 328 would need to be studied in more detail with further investigations. This observation has 390 potential physiological relevance given that GLP-1 secretion may be blunted/impaired in 391 patients with type 2 diabetes. For example, reduced postprandial concentrations of intact 392 biologically active GLP-1 have been observed in type 2 diabetic patients and it seem likely 393 that that these reductions in GLP-1 secretion result in impaired insulin secretion (Vilsbøll et 394 al., 2001) . Therefore our observation that 72 h MSG exposure leads to a decline in GLP-1 395 secretion suggests that it may be a contributing factor in the pathogenesis of diabetes/obesity.
396
A novel HCA assay measuring nuclear and mitochondrial parameters was developed to 397 assess the cellular health of EE cells under conditions of both 3 h and 72 h MSG exposure.
398
No cytotoxicity was evident when the EE cells were exposed to MSG for 3 h, however, 399 significant toxic effects were observed following 72 h exposure. Concentration-dependent 400 reductions in cell number and in mitochondrial membrane potential were observed, as were 401 increases in nuclear area and mitochondrial mass. (Ankarcrona et. al., 1995) . The results of the present study provide no evidence of 3 h toxic 411 effects, but again this can be due to a number of other factors including the cell type used, the 412 MSG concentrations employed and the duration of exposure.
413
In the present study there was a good association between the MSG concentrations that 414 caused decline in GLP-1 secretion and those which caused cytotoxic effects. At the highest 415 MSG concentration tested (500 μg/ml) there was a significant decrease in both cell number 416 and in mitochondrial membrane potential but a significant increase in mitochondrial mass and 417 nuclear area. It is well established that biogenesis of mitochondria can increase mitochondrial 418 mass as a result of increased mitochondrial respiration, and that this usually corresponds with 419 reduced mitochondrial membrane potential (O'Brien and Haskins, 2007) . Mitochondria are 420 organelles involved in the regulation of programmed cell death (apoptosis). This often occurs when cells are damaged by disease or toxic agents (Norbury and Hickson, 2001) . Due to the 422 increase in nuclear area observed in the study, it would appear that some cells underwent 423 necrosis. In the case of necrosis, the cells will swell and consequently cause an increase in 424 nuclear area, as observed in the present study. Although there are distinct differences in the 425 mechanisms of apoptosis and necrosis, there is overlap between the two processes described 426 as the "apoptosis-necrosis continuum" (Zeiss, 2003) and the results of the HCA assays 427 suggest that the highest concentration (500 μg/ml) of MSG is capable of inducing "apoptosis-428 necrosis continuum" in EE cells during the 72 h exposure.
429
The concentrations of MSG used in this study were based on dietary exposure levels, average 430 daily intakes across different populations and at levels higher than these levels to account for 431 underestimations in MSG intake (Collision et al., 2009; He et al., 2011; Nakanishi et al., 432 2008; Shi et al., 2014) . Maximum MSG solubility was achieved at 500 mg/ml, giving a top 433 concentration on the assay plate of 500 μg/ml, equivalent to an exposure of 30 g/day.
434
Although this is much higher than average daily intakes discussed, as outlined in the 435 introduction, restaurants add unknown amounts of MSG to foods, therefore it is difficult to 436 estimate accurate exposure and it is therefore possible certain groups of the population could 437 be exposed to these high levels, where the present study found significant effects.
438
Furthermore, in a society where MSG is not regulated and consumers are increasingly eating 439 out or purchasing take-away foods, it is not unreasonable to suggest that MSG exposure is 440 likely to be on the increase. It is also worth mentioning the potentially greater health risks 441 which Asian populations are being subjected to as a result of their excessive MSG exposure.
442
Large scale epidemiological studies are clearly warranted to provide better estimates of MSG 443 consumption. The setting of maximum levels of MSG content in foods is something which 444 should be given serious consideration. This would have the added benefit of improving the 445 accuracy of consumer exposure for this food additive. 
